Alnylam Releases Positive Early Results on Clinical Outcome Measures from ILLuminate-A Phase 3 Study of OXLUMO

Press/Media

Period6 May 2021

Media coverage

1

Media coverage

  • TitleAlnylam Releases Positive Early Results on Clinical Outcome Measures from ILLuminate-A Phase 3 Study of OXLUMO
    Media name/outletWireless News(Close-up Media)
    Country/TerritoryUnited States
    Date6/05/21
    PersonsJeffrey Saland
View all 1
View less